AAAAAA
Results: 1-25/49
Authors:
VASSAL G
BOLAND I
TERRIERLACOMBE MJ
WATSON AJ
MARGISON GP
VENUAT AM
MORIZET J
PARKER F
LACROIX C
LELLOUCHTUBIANA A
PIERREKAHN A
POULLAIN MG
GOUYETTE A
Citation: G. Vassal et al., ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY, Clinical cancer research, 4(2), 1998, pp. 463-468
Authors:
VASSAL G
BOLAND I
TERRIERLACOMBE MJ
WATSON AJ
MARGISON GP
VENUAT AM
MORIZET J
PARKER F
LACROIX C
LELLOUCHTUBIANA A
PIERREKAHN A
POULLAIN MG
GOUYETTE A
Citation: G. Vassal et al., ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY, Clinical cancer research, 4(2), 1998, pp. 463-468
Authors:
GOUYETTE A
Citation: A. Gouyette, TOPOISOMERASES - FOREWORD, Biochimie, 80(3), 1998, pp. 199-199
Authors:
VASSAL G
PONDARRE C
BOLAND I
CAPPELLI C
SANTOS A
THOMAS C
LUCCHI E
IMADALOU K
PEIN F
MORIZET J
GOUYETTE A
Citation: G. Vassal et al., PRECLINICAL DEVELOPMENT OF CAMPTOTHECIN DERIVATIVES AND CLINICAL-TRIALS IN PEDIATRIC ONCOLOGY, Biochimie, 80(3), 1998, pp. 271-280
Authors:
MASSAADMASSADE L
CHOUAIB S
GOUYETTE A
Citation: L. Massaadmassade et al., PHENOBARBITAL PREVENTS THE INHIBITORY EFFECTS OF TUMOR-NECROSIS-FACTOR ON GLUTATHIONE-S-TRANSFERASE-MU IN PRIMARY CULTURE RAT HEPATOCYTES, Anticancer research, 18(3A), 1998, pp. 1833-1838
Authors:
MASSAADMASSADE L
DOMENGE C
RONGEAT S
HASSOUN L
LEGROS MH
ROPERS J
JANOT F
PARISE O
GOUYETTE A
Citation: L. Massaadmassade et al., RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/, Anticancer research, 18(1A), 1998, pp. 283-288
Authors:
VANDIER D
RIXE O
BRENNER M
GOUYETTE A
BESNARD F
Citation: D. Vandier et al., SELECTIVE KILLING OF GLIOMA CELL-LINES USING AN ASTROCYTE-SPECIFIC EXPRESSION OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE, Cancer research, 58(20), 1998, pp. 4577-4580
Authors:
LENEEL T
MORLETRENAUD C
LIPART C
GOUYETTE A
TRUCHAUD A
MERLE C
Citation: T. Leneel et al., IMAGE-ANALYSIS AS A NEW TECHNIQUE FOR THE STUDY OF WATER-UPTAKE IN TABLETS, STP pharma sciences, 7(2), 1997, pp. 117-122
Authors:
EMERIT I
FILIPE P
MEUNIER P
AUCLAIR C
FREITAS J
DEROUSSENT A
GOUYETTE A
FERNANDES A
Citation: I. Emerit et al., CLASTOGENIC ACTIVITY IN THE PLASMA OF SCLERODERMA PATIENTS - A BIOMARKER OF OXIDATIVE STRESS, Dermatology, 194(2), 1997, pp. 140-146
Authors:
MORLET L
VONARX V
FOULTIER MT
GOUYETTE A
STEWART C
LENZ P
PATRICE T
Citation: L. Morlet et al., IN-VITRO AND IN-VIVO SPECTROFLUOROMETRY OF A WATER-SOLUBLE META-(TETRAHYDROXYPHENYL)CHLORIN (M-THPC) DERIVATIVE, Journal of photochemistry and photobiology.B, Biology, 39(3), 1997, pp. 249-257
Authors:
VASSAL G
PONDARRE C
CAPPELLI C
TERRIERLACOMBE MJ
BOLAND I
MORIZET J
BENARD J
VENUAT AM
ARDOUIN P
HARTMANN O
GOUYETTE A
Citation: G. Vassal et al., DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA, European journal of cancer, 33(12), 1997, pp. 2011-2015
Authors:
MASSAADMASSADE L
RIBRAG V
MARIE JP
FAUSSAT AM
BAYLE C
DREYFUS F
GOUYETTE A
Citation: L. Massaadmassade et al., GLUTATHIONE SYSTEM, TOPOISOMERASE-II LEVEL AND MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOGENOUS LEUKEMIA BEFORE TREATMENT AND AT RELAPSE, Anticancer research, 17(6D), 1997, pp. 4647-4651
Authors:
VONARX V
ELEOUET S
CARRE J
IOSS P
GOUYETTE A
LERAY AM
MERLE C
LAJAT Y
PATRICE T
Citation: V. Vonarx et al., POTENTIAL EFFICACY OF A DELTA-5-AMINOLEVULINIC ACID BIOADHESIVE GEL FORMULATION FOR THE PHOTODYNAMIC TREATMENT OF LESIONS OF THE GASTROINTESTINAL-TRACT IN MICE, Journal of Pharmacy and Pharmacology, 49(7), 1997, pp. 652-656
Authors:
VASSAL G
BOLAND I
SANTOS A
BISSERY MC
TERRIERLACOMBE MJ
MORIZET J
SAINTEROSE C
LELLOUCHTUBIANA A
KALIFA C
GOUYETTE A
Citation: G. Vassal et al., POTENT THERAPEUTIC ACTIVITY OF IRINOTECAN (CPT-11) AND ITS SCHEDULE DEPENDENCY IN MEDULLOBLASTOMA XENOGRAFTS IN NUDE-MICE, International journal of cancer, 73(1), 1997, pp. 156-163
Authors:
ALBIN N
MASSADE L
GOUYETTE A
Citation: N. Albin et al., USE AND APPLICATIONS OF PHARMACOGENETICS IN ONCOLOGY AND HEMATOLOGY, Bulletin du cancer, 84(6), 1997, pp. 643-651
Authors:
RIBRAG V
MASSADE L
FAUSSAT AM
DREYFUS F
BAYLE C
GOUYETTE A
MAIRE JP
Citation: V. Ribrag et al., DRUG-RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 10(12), 1996, pp. 1944-1949
Authors:
RAMIREZ LH
ZHAO ZX
ROUGIER P
BOGNEL C
DZODIC R
VASSAL G
ARDOUIN P
GOUYETTE A
MUNCK JN
Citation: Lh. Ramirez et al., PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS, Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 371-376
Authors:
VASSAL G
KOSCIELNY S
CHALLINE D
VALTEAUCOUANET D
BOLAND I
DEROUSSENT A
LEMERLE J
GOUYETTE A
HARTMANN O
Citation: G. Vassal et al., BUSULFAN DISPOSITION AND HEPATIC VENOOCCLUSIVE DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 247-253
Authors:
MARANINCHI D
BARBET J
BATTAIS J
EMILIE D
GOEHRS JM
GUINOT P
MANNONI P
MEYER P
ROMETLEMONNE JL
TROUVIN JH
CALVO F
GALANAUD P
GOUYETTE A
JULOU CL
MARCEL T
MOREL A
QUENTINMILLET MJ
SCHATZ C
WIJDENES J
Citation: D. Maraninchi et al., WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN, Therapie, 51(4), 1996, pp. 431-433
Authors:
VASSAL G
TERRIERLACOMBE MJ
LELLOUCHTUBIANA A
VALERY CA
SAINTEROSE C
MORIZET J
ARDOUIN P
RIOU G
KALIFA C
GOUYETTE A
Citation: G. Vassal et al., TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN, International journal of cancer, 69(2), 1996, pp. 146-151
Authors:
VASSAL G
TERRIERLACOMBE MJ
BISSERY MC
VENUAT AM
GYERGYAY F
BENARD J
MORIZET J
BOLAND I
ARDOUIN P
BRESSACDEPAILLERETS B
GOUYETTE A
Citation: G. Vassal et al., THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS, British Journal of Cancer, 74(4), 1996, pp. 537-545
Authors:
RIBRAG V
MASSAAD L
JANOT F
MORIZET J
GOUYETTE A
CHABOT GG
Citation: V. Ribrag et al., MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY, Leukemia & lymphoma, 18(3-4), 1995, pp. 303-310
Authors:
VONARXCOINSMAN V
FOULTIER MT
DEBRITO LX
MORLET L
GOUYETTE A
PATRICE T
Citation: V. Vonarxcoinsman et al., HEPG2 HUMAN HEPATOCARCINOMA CELLS - AN EXPERIMENTAL-MODEL FOR PHOTOSENSITIZATION BY ENDOGENOUS PORPHYRINS, Journal of photochemistry and photobiology.B, Biology, 30(2-3), 1995, pp. 201-208
Authors:
DOMENGE C
MASSADE L
RONGEAT S
HASSOUN L
LEGROS MH
JANOT F
JULIERON M
LUBOINSKI B
GOUYETTE A
Citation: C. Domenge et al., GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY, European journal of cancer, 31A, 1995, pp. 402-402
Authors:
DEROUSSENT A
LECAER JP
ROSSIER J
GOUYETTE A
Citation: A. Deroussent et al., ELECTROSPRAY MASS-SPECTROMETRY FOR THE CHARACTERIZATION OF THE PURITYOF NATURAL AND MODIFIED OLIGODEOXYNUCLEOTIDES, Rapid communications in mass spectrometry, 9(1), 1995, pp. 1-4